Literature DB >> 1384343

Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.

V Schilling1, B Negri, J Bujía, P Schulz, E Kastenbauer.   

Abstract

Cholesteatoma of the middle ear is characterized by the presence of hyperproliferative keratinizing squamous epithelium in the middle ear cavity and destruction of adjacent bone. Interleukin 1 (IL-1) is an autocrine growth factor for normal keratinocytes and is capable of inducing bone degradation. The distribution of two molecular species of IL-1, IL-1 alpha and IL-1 beta, was investigated immunohistochemically in the hyperproliferative epithelium of cholesteatoma, in normal epidermis of the auditory canal and of the retroauricular region, and in nonkeratinizing tonsillar epithelium. In all squamous epithelia examined, IL-1 alpha and IL-1 beta were present in comparable amounts. The IL-1 content of cholesteatoma epithelium was clearly increased in relation to normal skin keratinocytes. All cellular layers of cholesteatoma epithelium stained strongly and uniformly for Il-1 alpha and IL-1 beta, whereas the keratin layer was negative for IL-1. No particularly strong reaction with basal cells was detected. In the connective tissue under the squamous epithelium of cholesteatoma, intensely positive cells were scattered between negative stromal cells. Our results suggest that IL-1 could be liberated from disintegrating keratinocytes and cells of the monocyte-macrophage lineage, stimulate the proliferation of the cholesteatoma epithelium in an autocrine manner, and contribute to the enhancement of bone destruction in the presence of cholesteatoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384343

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  16 in total

1.  Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.

Authors:  J Bujia; H Sudhoff; A Holly; H Hildmann; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.

Authors:  J Bujía; C Kim; P Ostos; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

3.  Confirmation of mucin in lymphatic vessels of acquired cholesteatoma.

Authors:  Tomoyuki Nagai; Tatsuo Suganuma; Soyuki Ide; Hiroshi Shimoda; Seiji Kato
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-11-22       Impact factor: 2.503

4.  Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma.

Authors:  K Hochstrasser; G J Albrecht; W Gebhard; G Rasp; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

5.  Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma.

Authors:  Tolgahan Çatlı; Yıldırım Bayazıt; Akın Yılmaz; Adnan Menevşe; Ozan Gökdoğan; Nebil Göksu; Suat Özbilen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-06       Impact factor: 2.503

6.  In vivo over-expression of KGF mimic human middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Naotaro Akiyama; Yasuaki Shibata; Haruo Takahashi; Tohru Ikeda; Takehiko Koji
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-20       Impact factor: 2.503

7.  Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma.

Authors:  A Holly; M Sittinger; J Bujia
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

Review 8.  Etiopathogenesis of cholesteatoma.

Authors:  Ewa Olszewska; Mathias Wagner; Manuel Bernal-Sprekelsen; Jörg Ebmeyer; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-06-27       Impact factor: 2.503

9.  Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.

Authors:  Tomomi Yamamoto-Fukuda; Mariko Terakado; Yoshitaka Hishikawa; Takehiko Koji; Haruo Takahashi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-02       Impact factor: 2.503

10.  Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of protein production and biological activity.

Authors:  J Bujía; C Kim; P Ostos; H Sudhoff; E Kastenbauer; L Hültner
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.